ZA loops of bromodomains
AssigneesThe J. David Gladstone Institutes, Mt. Sinai School of Medicine
InventorsMing-Ming Zhou, Aneel K. Aggarwal, Eric Verdin, Melanie Ott
Life of this patent
Estimating the term…
Abstract
The present invention provides the structural determination of a bromodomain determined by NMR spectroscopy. The present invention also provides binding partners for the bromodomain. The present invention further provides the structural determination of the Tat-P/CAF binding complex determined by NMR spectroscopy. In addition, the present invention provides methodology for related drug discovery using high throughput drug screening or structure based rational drug design using the three-dimensional data.
Claims2
An isolated peptide consisting of a ZA loop of a bromodomain, and wherein said bromodomain is selected from the group consisting of SEQ ID NOs. 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36 , 37, 38, 39, 40, 41, and 42, and the ZA loop of SEO ID NO:
- 19.
A fusion protein or peptide consisting of a first sequence consisting of a ZA loop of a bromodomain according to one of SEQ ID NOs. 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36 , 37, 38, 39, 40, 41, and 42, and a second sequence consisting of the ZA loop of SEO ID NO:
- 19, and a third sequence from another protein.
Dependencies are inferred from the claim text.